Gene · 4043
Papers2,811
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,811
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Macrophage polarization and metabolism in atherosclerosis. | Cell Death Dis | 2023 | 37863894 | PubTator, text mining | PubMed |
Perturbation of 3D nuclear architecture, epigenomic aging and dysregulation, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 2-Metabolome, immunome, synaptome. | Front Psychiatry | 2023 | 37854446 | PubTator, text mining | PubMed |
| Genes expression profiles in vascular cambium of Eucalyptus urophylla × Eucalyptus grandis at different ages. | BMC Plant Biol | 2023 | 37848837 | PubTator, text mining | PubMed |
| CD44s-activated tPA/LRP1-NFκB pathway drives lamellipodia outgrowth in luminal-type breast cancer cells. | Front Cell Dev Biol | 2023 | 37842093 | PubTator, text mining | PubMed |
| Role of Semaphorin 3A in Kidney Development and Diseases. | Diagnostics (Basel) | 2023 | 37835781 | PubTator, text mining | PubMed |
| ROR2 homodimerization is sufficient to activate a neuronal Wnt/calcium signaling pathway. | J Biol Chem | 2023 | 37832874 | PubTator, text mining | PubMed |
A prospective, real-world, multinational study of febrile neutropenia (FN) occurrence in oncology patients receiving chemotherapy with intermediate risk of FN: a MASCC Neutropenia, Infection, and Myelosuppression Study Group initiative. | Support Care Cancer | 2023 | 37828258 | PubTator, text mining | PubMed |
| ATNC: Versatile Nanobody Chimeras for Autophagic Degradation of Intracellular Unligandable and Undruggable Proteins. | J Am Chem Soc | 2023 | 37826913 | PubTator, text mining | PubMed |
| Mechanistic insight into the role of AUXIN RESISTANCE4 in trafficking of AUXIN1 and LIKE AUX1-2. | Plant Physiol | 2023 | 37776522 | PubTator, text mining | PubMed |
| GPER Acts Through the cAMP/Epac/JNK/AP-1 Pathway to Induce Transcription of Alpha 2C Adrenoceptor in Human Microvascular Smooth Muscle Cells. | J Cardiovasc Pharmacol | 2023 | 37773889 | PubTator, text mining | PubMed |
| The endocytic receptor protein LRP-1 modulate P-glycoprotein mediated drug resistance in MCF-7 cells. | PLoS One | 2023 | 37768946 | PubTator, text mining | PubMed |
| Invasive Phenoprofiling of Acute-Myocardial-Infarction-Related Cardiogenic Shock. | J Clin Med | 2023 | 37762759 | PubTator, text mining | PubMed |
| Repositioning of HMG-CoA Reductase Inhibitors as Adjuvants in the Modulation of Efflux Pump-Mediated Bacterial and Tumor Resistance. | Antibiotics (Basel) | 2023 | 37760764 | PubTator, text mining | PubMed |
| Novel mutations of the X-linked genes associated with early-onset high myopia in five Chinese families. | BMC Med Genomics | 2023 | 37749571 | PubTator, text mining | PubMed |
| Phosphoproteomics reveals content and signaling differences between neonatal and adult platelets. | bioRxiv | 2023 | 37745418 | PubTator, text mining | PubMed |
| The prognostic value of whole-genome DNA methylation in response to Leflunomide in patients with Rheumatoid Arthritis. | Front Immunol | 2023 | 37744384 | PubTator, text mining | PubMed |
| Secreted LRPAP1 binds and triggers IFNAR1 degradation to facilitate virus evasion from cellular innate immunity. | Signal Transduct Target Ther | 2023 | 37743411 | PubTator, text mining | PubMed |
| PerTurboID, a targeted in situ method reveals the impact of kinase deletion on its local protein environment in the cytoadhesion complex of malaria-causing parasites. | Elife | 2023 | 37737226 | PubTator, text mining | PubMed |
| The discovery, structure, and function of 5-HTR1E serotonin receptor. | Cell Commun Signal | 2023 | 37723479 | PubTator, text mining | PubMed |
| Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry. | Respir Res | 2023 | 37715261 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4043/papers?page=11